Navigation Links
1/3 of Docs Often Prescribe Brand-Name Drugs Over Generics: Study
Date:1/8/2013

By Alan Mozes
HealthDay Reporter

TUESDAY, Jan. 8 (HealthDay News) -- More than a third of American doctors say they sometimes or often write prescriptions for pricier, brand-name drugs when a patient requests it, despite the availability of cheaper and equally effective generic options, a new national survey reveals.

The study also found that drug company marketing efforts might play a role in the trend. Doctors who accepted small freebies, such as free drug samples or food or drinks, were more likely to opt for brand-name drugs vs. physicians who did not, the research showed.

"The point is, industry marketing works," said study author Eric Campbell, a professor of medicine in the department of medicine at Harvard Medical School. "Despite the fact that controlling health care, and not wasting scarce resources, is a fundamental tenet of practicing medicine."

He said the added costs get passed on to everyone.

"The increased cost of prescribing non-generic drugs when generics are available are born by the patients in terms of higher co-pays and by society in the form of higher insurance premiums," Campbell noted.

"But, we found that 37 percent of doctors do this sometimes or often, despite the fact that the winners are always the drug companies and the losers are always the patients," he said.

"That figure, which is big already, is probably an underestimate," Campbell added, "because even though our survey was anonymous there's still going to be a reluctance among doctors to admit to doing something that would be perceived negatively."

The findings were reported online Jan. 7 in the journal JAMA Internal Medicine.

According to the U.S. Food and Drug Administration, generic drugs are "required to have the same active ingredient, strength, dosage form and route of administration as the brand name."

FDA statistics suggest that about 80 percent of all drugs taken in the Unite
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Docs Often Use Social Media on the Job: Survey
2. Cancer-Related Fatigue Often Overlooked, Study Finds
3. Fibromyalgia Diagnosis Often Missed in Men: Study
4. Males Struck by Cars Die More Often Than Females: Study
5. Breath Analyzers Often Unreliable in Houston DWI Cases, Says Attorney Joseph LaBella
6. Men with fibromyalgia often go undiagnosed, Mayo Clinic study suggests
7. For Psychiatric Patients, Cancer Is Often Spotted Too Late
8. People with HIV hospitalized less often since combination antiretroviral drug therapy introduced
9. Regenstrief study finds that generic drugs often have incorrect safety labeling
10. Study Reveals Why Elderly Often Vulnerable to Scams
11. Websites Touting Designer Vagina Surgeries Often Inaccurate, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
1/3 of Docs Often Prescribe Brand-Name Drugs Over Generics: Study
(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... The Canton Group, a leading web and ... today that Tim Dodge has joined the company as ... Canton Group as it implements an ambitious growth ... Tim is a tech industry veteran who has developed ... companies. Before joining The Canton Group, Tim was Vice ...
(Date:6/3/2015)... On June 22, 2015, Medicare will begin denying coverage ... that it has reimbursed since 2009. , Payment denial ... the 49 million Medicare beneficiaries in the U.S. who are ... Sadly, if it became a standard of care, this testing ... an individual’s genetic information to tailor treatment, is by all ...
(Date:6/3/2015)... 2015 Horizon Blue Cross Blue Shield of ... one of the nation’s top employers for diverse managers and ... its national list of Best Places for Diverse Managers and ... 1 Regional Company. This is the sixth consecutive year ... for its diverse workplace policies and programs. , Companies are ...
(Date:6/3/2015)... 03, 2015 A group of nine ... with a Global Inspire Award at DIA’s upcoming Annual ... outstanding volunteers for their leadership, level of excellence, and ... , The recipients of the Author(s) of the Year ... whose article has made a significant impact in advancing ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4
... the first long-term randomized trial of a chemopreventive agent for ... cancer in the drug-treated group may be attributable to shrinkage ... The study of the Prostate Cancer Prevention Trial, led by ... Gann, is published in the Sept. 12 issue of the ...
... Providers, SEATTLE, Sept. 12 , News Facts -- ... concerns and interests to the 2008 presidential candidates ... online physician community. -- The initiative is enabling U.S. licensed ... via individual web-based videos. Experts from a ...
... Wrinkles, HIGHLANDS, N.J., Sept. 12 Fifty really ... men in their 40s and 50s look better than,their ... can look incredibly sexy at any age. So ... keep the,attention of handsome himbos and beautiful babes? Biocap, ...
... Corporation,(Nasdaq: KNSY ) today announced that it will ... 30, 2007 at 7:00 A.M. Eastern Time on,Friday, October ... be hosting a teleconference,discussing the earnings results on Friday, ... participate in the teleconference call, dial 1-651-291-5254. The,teleconference call ...
... billion dollars. , But an unhealthy kidney costs moreabout ... associate professor in the division of nephrology and hypertension ... about $17 billion a year to care for patients ... currently over 320,000 people undergoing hemodialysis in the United ...
... Centers Head and Neck Cancer Center is teaming up ... cancer. The clinical alliance between Mount Sinai and ENT ... allergy and audiology practice in the tri-state area, together ... quality care, cancer screening and advanced surgical options for ...
Cached Medicine News:Health News:Shrinkage of prostate led to overestimation of cancer risk in trial 2Health News:U.S. Physicians Question Presidential Candidates 2Health News:Cougars Crave Biocap, The Haute Pepper Wrinkle Eraser 2Health News:Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference 2Health News:Clinical trials present better alternatives for dialysis patients 2Health News:Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer 2
(Date:6/3/2015)... 2015  SurgiQuest®, Inc. ("SurgiQuest", the "Company"), a ... invasive surgery (MIS) announced today that surgeons have ... procedures.  Adoption has risen rapidly with a 150% ... by the company,s expansion from robotics into the ... to over 45 countries.   The ...
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... 2015  EIP Pharma LLC ( www.eippharma.com ) today ... of VX-745 in Alzheimer,s disease (AD) is underway.  VX-745 ... inhibitor of the alpha isoform of the protein enzyme ... "Recent human genetic data demonstrate that inflammation is ... Alzheimer,s, while the science also indicates the p38 MAPK ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... Inc. ( www.bendresearch.com ), a leading independent drug-formulation development and ... Jim Nightingale, who has worked at the company since 1993, ... Nightingale will succeed Rod Ray, who will ... (CEO) and chairman of the board of directors. ...
... Mass., July 27, 2011 Magellan Biosciences, a ... testing easier, more cost-effective, and less labor intensive, ... Atlanta yesterday at the AACC Clinical Lab Expo. ... laboratories seeking to improve the workflow efficiency, cost-effectiveness, ...
Cached Medicine Technology:Bend Research Inc. Names New President 2Magellan's Dynex® Agility™ ELISA Processor Dramatically Reduces Laboratory Time and Labor in Diagnostic Testing While Ensuring the Most-Accurate Results 2Magellan's Dynex® Agility™ ELISA Processor Dramatically Reduces Laboratory Time and Labor in Diagnostic Testing While Ensuring the Most-Accurate Results 3
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve...
Ideal for short scleral tunnel and trabecular meshwork incisions...
Medicine Products: